CAH (Congenital Adrenal Hyperplasia) Deletion & Duplication Detection Test in UAE | 1400 AED | DHA Licensed

Executive Summary & Core Metrics

Precision Diagnostics for 21-Hydroxylase Deficiency CAH

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Post-Test Telephonic Consultation for Result Interpretation.
Insurance & Support: Direct Billing Verification and Test Inquiries via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The CAH Deletion & Duplication Detection test employs Multiplex Ligation-dependent Probe Amplification (MLPA) to identify pathogenic copy number variants in the CYP21A2 gene, enabling accurate diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia. This UAE-based genetic analysis offers a rapid 7–10 day turnaround with DHA-compliant interpretive reporting for endocrinologists, geneticists, and reproductive medicine specialists.

Feature	Our Test (MLPA)	Closest Alternative (Sanger Sequencing)
Precision	High-resolution copy number detection (deletions/duplications)	Point mutations only; limited copy number assessment
Method	Multiplex Ligation-dependent Probe Amplification (Gold Standard)	Chain-termination DNA sequencing (Sanger)
Speed	7–10 Days	2–3 Weeks Typical

Physician Insight & Safety Protocols

"As a Consultant Medical Genetics specialist, I recommend this MLPA-based deletion/duplication analysis for patients presenting with atypical genitalia, salt-wasting crises, or elevated 17-hydroxyprogesterone. Genetic confirmation is essential for long-term management and family counseling." – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.

Medication Advisory

Do not adjust or discontinue prescribed corticosteroid therapy without explicit guidance from your managing endocrinologist. Abrupt cessation can precipitate an adrenal crisis, which is a life-threatening emergency.

Exclusion Criteria & Red Flags

Not suitable for patients who have undergone recent blood transfusion (within 4 weeks).
Active hematological disorders that may compromise sample integrity.
ER Red Flags: Seek immediate medical attention if you experience severe vomiting, dehydration, low blood pressure, or symptoms of adrenal crisis following blood draw.

Patient FAQ & Clinical Guidance

1. What does the CAH deletion/duplication test detect?

This MLPA-based analysis precisely detects CYP21A2 gene deletions and duplications responsible for 21-hydroxylase deficiency congenital adrenal hyperplasia, determining carrier status and confirming clinical diagnosis.

2. Is a doctor’s prescription needed for this test?

A valid doctor’s prescription is generally required. Exceptions may be made for pre-surgical clearance, pregnancy-related testing, or international travel documentation upon clinical assessment and approval by our medical team. Please contact our support team to confirm eligibility.

3. How fast are results available?

Results are delivered within 7–10 days via ISO-accredited MLPA analysis with DHA-compliant interpretive reporting, accessible securely online through our patient portal.

UAE Regulatory & Data Privacy Adherence

DNA Labs UAE strictly adheres to the following legal frameworks:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring your genetic data is processed lawfully, transparently, and stored securely.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure handling of electronic health records.
Federal Decree-Law No. 4 of 2016 on Medical Liability – safeguarding patient consent and clinical safety throughout the diagnostic pathway.
DHA/MOHAP Standard Nomenclature compliance maintained across all reporting systems.

Clinical & Logistical Metadata

Test Name	CAH Deletion & Duplication Detection
Price (AED)	1400 AED
Turnaround Time	7–10 Days
Sample Type / Matrix	Peripheral Whole Blood (3–5 mL in EDTA) – VIP Mobile Phlebotomy Available
Methodology Used	Multiplex Ligation-dependent Probe Amplification (MLPA) – Gold Standard for CNV Detection
ICD-10-CM Code	E25.0 (Congenital adrenogenital disorders associated with enzyme deficiency)
LOINC Code	94219-1 (CYP21A2 gene deletion/duplication detection)
DHA Facility License & Laboratory Address	License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians